Jihong Liu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024

Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Jihong liuXiaoyan kangHanmei louEastern cooperative oncology group performance statusQilu pharmaceutical clinical research development centerSun yat sen university cancer centerEuropean society of gynecological oncologyEvaluation committeeEuropean societyGynecological oncologyQilu pharmaceuticalProfessor jihong liuIndependent evaluation committeeZhejiang cancer hospitalExecutive deputy general managerClinical research

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chao zengPei dongUnited statesRhui zhouYing yuanYu chenEli lillyHaibo qiuJihui haoAdimab incyteXiaohua wuInnovent biologicsZhichao jiangRui hua xuZhiguo luoYiwen chen

Frontline SHR-1701 Plus BP102 and Chemo Shows Potent Activity in Cervical Cancer

The novel bifunctional fusion protein SHR-1701 combined with standard first-line treatment with the bevacizumab biosimilar BP102 and platinum-doublet chemotherapy produced high, durable responses and was deemed tolerable in patients with cervical cancer.

Jihong liuSun yat sen university cancer centerShr 1701Cervical cancerPhase 1b portion of an ongoing 3 trial

Qilu Pharmaceutical Announces Progress of Clinical Study of QL1706, an Innovative Bifunctional Antibody

JINAN, China, Dec. 29, 2022 /PRNewswire/ In 2022, Qilu Pharmaceutical revealed the latest progress being made with several clinical studies inv.

Li zhangUnited statesNaifu liuWenfeng fangZhi liuBryan huangJihong liuYuxiang maAsia congresssHongyun zhaoWilliamc fanslowDanbo wangAmerican association for cancer researchAmerican association for cancer research annual meetingAmerican society of clinical oncologySasia congress